BSR operates four biologics and biosimilars registers; three for adult patients and one for children and young adults.
The data collected from the registers generates vital evidence on patient safety in the long term as well as the efficacy of treatment.
Members and non-members can access this data for research purposes – find out more below.
Data requests are regularly reviewed by our Registers' and Research Committee. There are three deadlines by which data requests should be submitted: the end of January, May, and October. To ensure that your data access request is reviewed in a timely fashion, please submit your data access requests prior to these dates.
Requesting registers data
At BSR, we’re committed to recognising individuals, services, and organisations that demonstrate excellence in delivering patient-centred care.
We’re especially proud to celebrate the outstanding people behind the success of the BSR biologics and biosimilars registers.
Meet our current Registers Champions — learn from their experiences and be inspired by their dedication to improving patient care.
Our Registers Champions
To better understand how the BSR Biologics Registers are experienced and valued at a local level, a perception survey was conducted in 2025, gathering responses from a broad range of rheumatology professionals across the UK. Participants included consultants, specialist nurses, pharmacists, researchers and administrative staff, reflecting the multidisciplinary teams that underpin register delivery in everyday practice.
The findings present a clear and consistent message: the registers are highly valued as a source of trusted, real-world evidence.
To read the full report, click here